Ovarian SAHA Syndrome Is Associated With a More Insulin-Resistant Profile and Represents an Independent Risk Factor for Glucose Abnormalities in Women With Polycystic Ovary Syndrome: A Prospective Controlled Study

    October 2013 in “ Journal of The American Academy of Dermatology ”
    Maria Dalamaga, Evangelia Papadavid, Georgios Basios, V. Vaggopoulos, Dimitrios Rigopoulos, Dimitrios Kassanos, Eftihios Trakakis
    Image of study
    TLDR Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.
    In 2013, a prospective controlled study involving 316 women with PCOS, of whom 56 had ovarian SAHA syndrome, and 102 healthy controls, found that ovarian SAHA syndrome is associated with a more insulin-resistant profile and is an independent risk factor for glucose abnormalities in women with PCOS. The study showed that women with SAHA had higher HOMA-IR scores and lower MATSUDA indices, indicating lower insulin sensitivity. The presence of SAHA was also linked to a more severe PCOS phenotype. The study highlighted the importance of early recognition of SAHA in women with PCOS for the early diagnosis and monitoring of metabolic abnormalities, suggesting that these women may benefit from lifestyle changes and insulin sensitizers like metformin to manage their condition and reduce the risk of developing type 2 diabetes. However, further research is needed to explore the potential cardiovascular risks associated with this insulin-resistant profile.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 97 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  448 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Bryan Johnson just dropped his anti hair loss formula

      in Treatment  339 upvotes 10 months ago
      Bryan Johnson shared his hair loss treatment, which mainly relies on minoxidil and finasteride. Some users are skeptical of his results, while others appreciate his efforts in anti-aging and hair loss research.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    6 / 6 results